(Libourne, France - September 4, 2014)   Ceva Animal Health announced the appointment of Dr. Steve Chu to its executive committee with responsibility for all Research and Development activities. The move recognizes the growing importance of biotechnology and the resulting convergence of pharmaceutical and biological research.

Dr.Chu joined Ceva in 2011 and has an outstanding record throughout his 30 year career in veterinary research. He previously held senior research positions with Fort Dodge, Elanco and Pfizer animal health. He is known throughout the industry for his work in developing several first-of–its kind, novel animal vaccines. Dr. Chu received the Center for Disease Control Director’s Innovation Award for his contribution to the development of an Equine West Nile virus vaccine.

Dr. Chu will remain based in the U.S. where he successfully leads Ceva’s biology R&D, and will add responsibility for global pharmaceutical research to his current role. Dr. Chu’s nomination will place an accent on speed of scientific innovation and a first- hand knowledge of the US and Chinese markets at the centre of the Ceva board.